Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome

Journal of Clinical Investigation

Volumn 98, Issue 1, 1996, Pages 30-35

  Yamamoto, Takehisa ^a   Ozono, Keiichi ^b   Kasayama, Soji ^a   Yoh, Kosei ^c   Hiroshima, Kazuo ^d   Takagi, Miki ^a   Matsumoto, Sayuri ^a   Michigami, Toshimi ^a   Yamaoka, Kanji ^a   Kishimoto, Tadamitsu ^a   Okada, Shintaro ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d OSAKA NATIONAL HOSPITAL   (Japan)

Author keywords

cAMP; fibrous dysplasia; G(S) protein; osteoclast; Paget's disease

Indexed keywords

CYCLIC AMP; GUANOSINE TRIPHOSPHATASE; INTERLEUKIN 6;

ADOLESCENT; ADULT; ALBRIGHT SYNDROME; ARTICLE; BONE BIOPSY; CAFE AU LAIT SPOT; CASE REPORT; ENDOCRINE DISEASE; ENZYME ACTIVITY; FEMALE; FIBROUS DYSPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OSTEOCLAST; PAGET BONE DISEASE; POINT MUTATION; PRIORITY JOURNAL;

EID: 8944222565     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118773     Document Type: Article

References (31)

1. Spiegel, A.M., A. Shenker, and L.S. Weinstein. 1992. Receptor effector coupling by G proteins: implications for normal and abnormal signal transduction. Endocr. Rev. 13:536-565.
2. Les, P.A., C. Van Dop, and C.J. Migeon. 1986. McCune-Albright syndrome: long term follow-up. J. Am. Med. Assoc. 256:2980-2984.
3. Weinstein, L.S., A. Shenker, P.V. Gejman, M.J. Merino, E. Friedman, and A.M. Spiegel. 1991. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 325:1688-1695.
4. Schwindinger, W.F., C.A. Francomano, and M.A. Levine. 1992. Identification of a mutation in the gene encoding the a subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc. Natl. Acad. Sci. USA. 89:5152-5156.
5. Shenker, A., L.S. Weinstein, A. Moran, O.H. Pescovitz, N.J. Charest, C.M. Boney, J.J. Van Wyk, M.J. Merino, P.P. Feullan, and A.M. Spiegel. 1993. Severe endocrine and non endocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J. Pediatr. 123:509-518.
6. Landis, C.A., S.B. Masters, A. Spada, A.M. Pace, H.R. Bourne, and L. Vallar. 1989. GTPase inhibiting mutations activate the a chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature (Lond.). 340:692-696.
7. sα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J. Clin. Endocrinol. & Metab. 79:750-755.
8. sα gene. Hum. Mol. Genet. 4:1675-1676.
9. Liens, D., P.D. Delmas, and P.J. Meunier. 1994. Long term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 343:953-954.
10. O'Doherty, D.P., D.R. Bickerstaff, E.V. McCloskey, N.A.T. Handy, M.N.C. Beneton, S. Harris, M. Mian, and J.A. Kanis. 1990. The treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate. J. Bone Miner. Res. 5:483-491.
11. Fleisch, H. 1993. Bisphosphonates in osteoporosis: an introduction. Osteoporosis Int. 3:53-55.
12. Yamamoto, T., N. Kurihara, K. Yamaoka, K. Ozono, M. Okada, K. Yamamoto, S. Matsumoto, T. Michigami, J. Ono, and S. Okada. 1993. Bone marrow-derived osteoclast-like cells from a patient with craniometaphyseal dysplasia lack expression of osteoclast reactive vacuolar proton pump. J. Clin. Invest. 91:362-367.
13. Yoneda, T., M. Nakai, K. Moriyama, L. Scott, N. Ida, T. Kishimoto, and G.R. Mundy. 1993. Neutralizing antibodies to human interleukin-6 reverse hypercalcemia associated with a human squamous carcinoma. Cancer Res. 53:737-740.
14. Jilka, R.L., G. Hangoc, G. Girasole, G. Passeri, D.C. Williams, J.S. Abrams, B. Boyce, H. Broxmeyer, and S.C. Manolagas. 1992. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science (Wash. DC). 257:88-91.
15. Roodman, G.D., N. Kurihama, Y. Ohsaki, A. Kukita, D. Hosking, A. Demulder, F.J. Smith, and F.R. Singer. 1992. Interleukin-6: a potential autocrine/ paracrine factor in Paget's disease of bone. J. Clin. Invest. 89:46-52.
16. Since, E.S. 1993. Paget's disease of bone. In Primers on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 2nd ed. M.J. Fravus, editor. Raven Press, New York. 375-384.
17. Kishimoto, T. 1989. The biology of interleukin-6. Blood. 74:39-48.
18. Utiger, R.D. 1994. Subclinical hyperthyroidism-just a low serum thyrotropin concentration, or something more? N. Engl. J. Med. 331:1302-1303.
19. Yamaoka, K., H. Tanaka, H. Kurose, M. Shima, K. Ozono, S. Nakajima, and Y. Seino. 1989. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets. Bone Miner. 7:159-169.
20. Frost, H.M. 1958. Preparation of thin decalcified bone sections by rapid manual method. Stain Technol. 33:273-277.
21. Yamamoto, T., B. Ecarot, and F.H. Glorieux. 1991. In vivo osteogenic activity of isolated human bone cells. J. Bone Miner. Res. 6:45-51.
22. Delmas, P.D. 1993. Markers of bone formation and resorption. In Primers on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 2nd ed. M.J. Fravus, editor. Raven Press, New York. 108-112.
23. - channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO (Eur. Mol. Biol. Organ.) J. 13:1065-1072.
24. sα: chronic transcriptional activation of the c-fos proto-oncogene in endocrine cells. J. Biol. Chem. 269: 22663-22671.
25. Abate, C., and T. Curran. 1990. Encounters with Fos and Jun on the road to AP-1. Semin. Cancer Biol. 1:19-26.
26. Candeliere, G.A., F.H. Glorieux, J. Preud'homme, and R.S. Arnaund. 1995. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N. Engl. J. Med. 332:1546-1551.
27. Pendorfer, V., P. Oettgen, and T.A. Libermann. 1994. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 14:4443-4454.
28. Passeri, M., G. Girasole, N. Giuliani, M. Pedrazzoni, E. Roti, M. Salvi, R. Minelli, C. Gatti, and C. Campanini. 1995. Serum soluble interleukin-6 receptors and interleukin-6 are increased in Grave's disease and correlated with thyroid hormones levels. J. Bone Miner. Res. 10(Suppl. 1):S143a. (Abstr.)
29. Girasole, G., G. Passeri, R.L. Jilka, and S.C. Manolagas. 1994. Interleukin-11: a new cytokine critical for osteoclast development. J. Clin. Invest. 93: 1516-1524.
30. McKinley, D., Q. Wu, T. Yang-Feng, and Y.C. Yang. 1992. Genomic sequence and chromosomal location of human interleukin-11 gene (IL-11). Genomics. 13:814-819.
31. Ellias, J.A., W. Tang, and M.C. Horowitz. 1995. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology. 136:489-498.